BUSINESS BRIEFING / BIOTECH
- Share via
TIMES WIRE REPORTS
Biotechnology company Amgen Inc. said Rebecca Henderson had been appointed to its board of directors.
Henderson, 48, recently became a professor at Harvard Business School. She has been a director at Idexx Laboratories Inc. since 2003.
Her appointment expands the size of Thousand Oaks-based Amgen’s board to 13.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
